Hongbo Wu

1.6k citations
50 papers · 826 indexed · h-index 17
Topics
Lung Cancer Treatments and Mutations (9 papers)MicroRNA in disease regulation (8 papers)Cancer-related molecular mechanisms research (7 papers)
Partner nations
ChinaSingaporeThailand

In The Last Decade

Hongbo Wu

49 papers receiving 810 citations

Peers

Hongbo Wu
Comparison fields: 5 of 106
  • Molecular Biology 352
  • Cancer Research 227
  • Immunology 170
  • Pulmonary and Respiratory Medicine 131
  • Cell Biology 129
Replace Yuki Otsuki with:
Yuki Otsuki Japan
Xiaoxi Xu China
Michael Bzorek Denmark
Jiale Qin China
Gianluca Santamaria Italy
Yunhee Lee South Korea
Anna Pastò Italy
Shinya Oda Japan
Hongbo Wu relative to Yuki Otsuki Japan Yuki Otsuki's profile →
Citations per field
00.5×4.2×
Yuki Otsuki · 1×
Citations per year

Countries citing papers authored by Hongbo Wu

Since Specialization
Citations

This map shows the geographic impact of Hongbo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Wu more than expected).

Fields of papers citing papers by Hongbo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Wu. The network helps show where Hongbo Wu may publish in the future.

Co-authorship network of co-authors of Hongbo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbo Wu. A scholar is included among the top collaborators of Hongbo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbo Wu. Hongbo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 5
4 7
5 18
6 6
7 111
8 18
9 13
10 23
11 1
12
Dynamic Analysis of Bridge Tower under Wind and Wave Action
2
13 42
14 13
15
Dynamic Analysis and Vibration Reduction Control for Structure With MTMD Under Wave Action
2
16 24
17 35
18 12
19 46
20 74

About Hongbo Wu

Hongbo Wu is a scholar working on Cancer Research, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 826 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (227 citations), Reproductive Medicine (71 citations) and Immunology (170 citations). Hongbo Wu has collaborated with scholars based in China, Singapore and Thailand. Frequent co-authors include Xiaoqian Mu, Yanqiu Zhao, Xiufeng Hu, Wenjing Liu, Huijuan Wu, Yu Mu, Lijuan Chen, Jie Liu, Fangfang Yuan and Lei Liu. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026